531592 — Genpharmasec Balance Sheet
0.000.00%
- IN₹869.34m
- IN₹928.16m
- IN₹337.22m
- 38
- 33
- 11
- 13
Annual balance sheet for Genpharmasec, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 112 | 40.6 | 29.5 | 205 | 52.7 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 78.7 | 75.4 | 62.4 | 115 | 136 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 268 | 215 | 189 | 410 | 273 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.483 | 1.04 | 1 | 8.39 | 75.8 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 278 | 217 | 199 | 711 | 799 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 71.6 | 62.8 | 20.6 | 27 | 98.4 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 71.6 | 62.8 | 45.4 | 67.3 | 147 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 207 | 154 | 153 | 644 | 652 |
| Total Liabilities & Shareholders' Equity | 278 | 217 | 199 | 711 | 799 |
| Total Common Shares Outstanding |